2008 "Sail into Summer" - WBBA Summer Social

You’re invited to the WBBA’s Summer Social, better known as the “bioscience bash of the year.” This year’s opportunity to meet and chat with your fellow WBBA members will be at the Naval Reserve Center at South Lake Union Park on July 17 from 4:30-7:30 p.m. “Sail Into Summer” will feature live music, appetizers, beverages and a number of wild and crazy sponsor displays. To sponsor, follow the link below or email pamlove@washbio.org.
Register Today!
Sponsor information
|
|
Register Now! WBBA Golf Invitational August 22
Play golf with 100 + of your best bioscience friends on Friday, August 22 at the 4th Annual WBBA Golf Invitational. Mark your calendar for a morning on the greens and a relaxing luncheon to follow at beautiful Trilogy Golf Course in Redmond. We’d like to recognize our sponsors to date: Townsend and Townsend and Crew LLP (Premier Sponsor); Seed IP Law Group PLLC (Photo Sponsor); Lease Crutcher Lewis (Beverage Cart Sponsor); Skilled Hole Sponsors AH&T and Wells Fargo Insurance Services and Hole Sponsors ABD Insurance; BNBuilders, Inc.; Darby & Darby, P.C.; Parker/Smith/Feek; Prudential Cleanroom Services; and VCFO.
More sponsorships are available, so check for sponsorships and reserve online or contact pamlove@washbio.org for more information. Register to play: $225 individual; $900 foursome. For more information contact patti@washbio.org.
Register Today!
Sponsorship Opportunities
|
|
|
Local News...
Free News Release Posting & Archiving Service
- Insecticide Movento(R) approved in United States and Canada The new insecticidal active ingredient spirotetramat from Bayer CropScience has been granted regulatory approval in the strategically important markets in the United States and Canada. Spirotetramat will be marketed worldwide under the brand name Movento(R).
Bayer July 03, 2008
- Wyeth and Progenics receive approval from European Commission for RELISTOR Wyeth Pharmaceuticals, a division of Wyeth, and Progenics Pharmaceuticals announced that the companies have received marketing approval for RELISTOR(TM) (methylnaltrexone bromide) subcutaneous injection from the European Commission.
Progenics Pharmaceuticals, Inc. July 03, 2008
- Orelle concludes phase ll clinical trials Orelle Corportion (Seattle) announces the conclusion of Phase ll Clinical Trials for its Pelvic Floor Muscle Exercise Device and related Exercise Program for the Relief and Prevention of Urinary Stress Leakage in Women at the Auckland University of Technology in New Zealand.
Orelle Corporation Ltd. July 03, 2008
- Orelle awarded Price Waterhouse Investor Choice Award Orelle Corporation (Seattle), developer of a Pelvic Floor Muscle Exercise Device for the Relief and Prevention of Urinary Stress Leakage in Women was awarded the Price Waterhouse 'Investor Choice Award for the Best Pre-Revenue Company' at the recent Vancouver, BC Angel Investment Forum.
Orelle Corporation Ltd July 03, 2008
- Bayer HealthCare acquires hematology development portfolio featuring MAXY-VII from Maxygen Bayer HealthCare is expanding its commitment to hemophilia with the acquisition of Maxygen's hemophilia program assets, including a next-generation recombinant Factor VIIa protein known as MAXY-VII. The lead therapeutic candidate is expected to enter Phase 1 clinical testing in 3Q 2008.
Bayer July 02, 2008
More... | Submit News Release | National News
|
New Job Postings...
The Recruiter’s Studio: People, Careers, Conversations
More... |
Job Advertising...
|
New Facilities Available...
ATC clean room constructors...validation guaranteed!
More... |
Facility Advertising...
|
Upcoming Events...
UW Master in Medical Engineering evening classes: Apply by Aug. 18
HDMA’s Looking Forward in Reverse Logistics Healthcare Seminar - Sept. 22-23 - Dallas, TX
More... |
Submit Event |
Event Advertising...
|
|